Mylan wins FDA nod for version of Merck's Hyzaar; Acino: Recall of generic Plavix clobbers results;

 @FiercePharma: Paper: Roche, Novartis threaten to leave UK. Story | Follow @FiercePharma

> Mylan won FDA approval to sell a generic version of Merck's blood pressure pill Hyzaar. Report

> Swiss drugmaker Acino says its 2010 figures would be hit hard after various European countries recalled batches of its generic heart drug Plavix made at a factory in India. Story

> World's largest drugmaker Pfizer, which had plans to hike its stake in its Indian arm Pfizer India to 75 percent as per its announcement in April 2009, has increased its stake to 70.75 percent in the Indian company. Report

> Closely held pharmaceutical company Nycomed still plans to launch an initial public offering despite a U.S. advisory panel voting not to recommend its lung drug Daxas. Report

> Javelin Pharmaceuticals received a better acquisition offer from Hospira, and it plans to end a competing bid made by Myriad Pharmaceuticals. Report

> Solvay Healthcare, Pfizer and Procter & Gamble were all found to have breached the Association of the British Pharmaceutical Industry's code of practice, which sets standards for the promotion of medicines by the industry to healthcare professionals. Report

> Data presented at the American Academy of Neurology (AAN) annual meeting add to the accumulating evidence of the positive benefit/risk profile of Gilenia, a potential first-in-class, once-daily oral therapy for relapsing forms of multiple sclerosis (MS). Report

> Roche AG has acquired insulin pump developer Medingo Ltd. from Elron Electronic Industries Ltd.  and its partners for $160 million as well as up to $40 million in milestone payments. Report

Biotech News

 @FierceBiotech: Biotechs cater to the most creative scientists. Article | Follow @FierceBiotech

 @JohnCFierce: Hey, stock watchers. What's up with Rexahn shares, up 27% this morning? corporate update sched. for tomorrow. Story  | Follow @JohnCFierce

> Mersana, Teva ink $334M deal for preclinical cancer drug. Story

> Novartis unveils more positive data for oral MS drug Gilenia. Item

> Roche: Still looking for deals in 2010. Article

> Nautilus gets funding to support migraine drug launch. Report

Biotech Research News

> Nanosensors used to detect blood disease biomarker. Story

> Researchers take a fresh look at hallucinogens. Report

> Faulty cleanup process could be key to Huntington's. Item

> Supramap helps researchers track, predict infectious disease. Article

> New approach could 'turn off' rheumatoid arthritis. Story

Manufacturing News

> FDA's import-screening program sidelined by IT issues. Report

> Analysts: India's hobbled logistics infrastructure needs big investments fast. News

> Ghana pharma ramps up with generics facility investor. Article

> I/O-room mock-up yields big savings in automation retrofit. Story

> Oregon's wooing pulls Genentech north for $400 million facility. Story

And Finally... Donald Trump and his partners won control of the bankrupt casino company Trump Entertainment Resorts Inc., when a judge ruled that their bid was better for creditors than a competing offer by investor Carl Icahn. Story

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.